Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2289]

Update on post-operative complications in older patients

Dr Kwok-Leung Cheung - Nottingham University, Nottingham, UK

Update on post-operative complications in older patients ( Dr Kwok-Leung Cheung - Nottingham University, Nottingham, UK )

Cancer Core Europe: Consortium to address the care-research continuum challenge

Prof Lex Eggermont, Prof Carlos Caldas, Prof Ulrik Ringborg

Cancer Core Europe: Consortium to address the care-research continuum challenge ( Prof Lex Eggermont, Prof Carlos Caldas, Prof Ulrik Ringborg )

EORTC and the management of clinical trial data

Anastassia Negrouk - European Organisation for Research and Treatment of Cancer...

EORTC and the management of clinical trial data ( Anastassia Negrouk - European Organisation for Research and Treatment of Cancer, Brussels, Belgium and Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )

Molecular targeting in cancer and the impact on personalised medicine

Prof Christian Dittrich - Ludwig Boltzmann Institute for Applied Cancer...

Molecular targeting in cancer and the impact on personalised medicine ( Prof Christian Dittrich - Ludwig Boltzmann Institute for Applied Cancer Research, Vienna, Austria )

Optimising metastic renal cell carcinoma (mRCC): Treatment lessons from the...

Dr Thomas Hutson - Baylor University Medical Center, Dallas, USA

Optimising metastic renal cell carcinoma (mRCC): Treatment lessons from the real world: Introduction ( Dr Thomas Hutson - Baylor University Medical Center, Dallas, USA )

Current treatment options in mRCC

Dr Thomas Hutson - Baylor University Medical Center, Dallas, USA

Current treatment options in mRCC ( Dr Thomas Hutson - Baylor University Medical Center, Dallas, USA )

Discussion: Additional treatment options impact first-line treatment of mRCC

Dr Thomas Hutson; Prof Stéphan Oudard; Prof Patrick Schöffski; Dr Ignacio Durán

Discussion: Additional treatment options impact first-line treatment of mRCC ( Dr Thomas Hutson; Prof Stéphan Oudard; Prof Patrick Schöffski; Dr Ignacio Durán )

From clinical trial to clinical practice: Evidence from the real world

Dr Ignacio Durán - Associate Director of Clinical Research at START Madrid...

From clinical trial to clinical practice: Evidence from the real world ( Dr Ignacio Durán - Associate Director of Clinical Research at START Madrid, Madrid, Spain )

The evolving treatment landscape for HER2-positive metastatic breast cancer

Dr Hatem Azim - Institut Jules Bordet, Brussels, Belgium

The evolving treatment landscape for HER2-positive metastatic breast cancer ( Dr Hatem Azim - Institut Jules Bordet, Brussels, Belgium )

Navigating current treatment options for HER2-positive MBC: Patient journey 1

Dr Rupert Bartsch - Medical University of Vienna, Vienna, Austria

Navigating current treatment options for HER2-positive MBC: Patient journey 1 ( Dr Rupert Bartsch - Medical University of Vienna, Vienna, Austria )

Thrombosis in adult patients with chronic ITP

Dr Howard Liebman - University of Southern California, Los Angeles, USA

Thrombosis in adult patients with chronic ITP ( Dr Howard Liebman - University of Southern California, Los Angeles, USA )

Global prostate cancer disparities and the parts both genetic and behavioural...

Dr Folakemi Odedina - College of Pharmacy, University of Florida, Gainesville...

Global prostate cancer disparities and the parts both genetic and behavioural factors play ( Dr Folakemi Odedina - College of Pharmacy, University of Florida, Gainesville, USA )

More from ecancer